Psychosomatics
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Podewils, L. J.
* Articles by Lyketsos, C. G.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Podewils, L. J.
* Articles by Lyketsos, C. G.
Related Collections
* Antidepressants
Psychosomatics 43:31-35, February 2002
© 2002 The Academy of Psychosomatic Medicine

Tricyclic Antidepressants and Cognitive Decline

Laura Jean Podewils, and Constantine G. Lyketsos, M.D., M.H.S.

Received June 15, 2001; revised October 10, 2001; accepted October 18, 2001. From the Departments of Epidemiology and Mental Hygiene, Johns Hopkins Bloomberg School of Public Health, and the Neuropsychiatry Service, Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, MD. Address correspondence and reprint requests to Dr. Lyketsos, Johns Hopkins Medical Institutions, 600 N. Wolfe St, Osler 320, Baltimore, MD 21287. E-mail: kostas{at}jhmi.edu

In this study, we sought to determine the cross-sectional and longitudinal relations of tricyclic antidepressant (TCA) use to cognitive function and cognitive change in a population-based sample of adults (n=1,488). Sociodemographic information, TCA use, and baseline scores on the Mini-Mental State Exam (MMSE) were determined in the initial two waves of the study. At wave 3, participants repeated the MMSE; the prospective relation was assessed for change between waves 2 and 3 (median 11.5 years). These findings failed to support the concept that TCA use is related to concurrent measurable cognitive deficits, and TCA use does not appear to significantly compromise memory over a substantial time span.

Key Words: Depression • Cognition




This article has been cited by other articles:


Home page
J Geriatr Psychiatry NeurolHome page
J. O. Brooks and J. C. Hoblyn
Neurocognitive Costs and Benefits of Psychotropic Medications in Older Adults
J Geriatr Psychiatry Neurol, December 1, 2007; 20(4): 199 - 214.
[Abstract] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
P. M. Doraiswamy, K. R. R. Krishnan, T. Oxman, L. R. Jenkyn, D. J. Coffey, T. Burt, and C. M. Clary
Does Antidepressant Therapy Improve Cognition in Elderly Depressed Patients?
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2003; 58(12): M1137 - 1144.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2002 Academy of Psychosomatic Medicine. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. Academy of Psychosomatic Medicine
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org